Pharmaceutical stocks, including Pfizer (NYSE: PFE ... rebounded after Wall Street analysts highlighted the significant legal challenges the order would face. The pharmaceutical industry has ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

According to InvestingPro data, the company faces significant financial challenges ... ITIL agreed to cover a transaction fee and Pfizer’s legal expenses. Iterum’s CEO, Corey Fishman ...

In a landmark decision that challenges the European Commission’s transparency standards, the General Court of the European ...

Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's ...

positioning it well for future growth despite recent market challenges. The legal battle began in 2020 when Pfizer accused SK bioscience of infringing on the composition patent of its own vaccine ...

The Pfizer Middle East, Russia and Africa (MERA) Maternal Immunization Summit: Born Ready brought together more than 80 ...

Nothing stopped red states from "challenging the scope of FDA’s authority or its decisionmaking" before Dobbs ruling, DOJ says. "We're simply asking DOJ to step aside and let us handle ...

The European Court of Justice has upheld a transparency challenge over undisclosed text messages between EU Commission ...

From making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and flows in the love story ...